Carl Anthony Evans serves as Executive at CNS Pharmaceuticals, Inc., where they oversee executive responsibilities. Since joining the company, Carl Anthony Evans has executed 2 insider transactions totaling $10.0K, demonstrating a bullish approach to their equity position. Their most recent transaction on Feb 1, 2024 involved purchasing 33,333 shares valued at $10.0K.
Carl Anthony Evans currently holds 33,458 shares of CNS Pharmaceuticals, Inc. (CNSP), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Carl Anthony Evans has been a net buyer of CNSP stock. They have purchased $10.0K and sold $0 worth of shares.
Carl Anthony Evans's most recent insider trade was on Feb 1, 2024, when they purchased 33,333 shares at $0.30 per share.
Get notified when new Form 4 filings are submitted
| $0.27 |
| Discretionary |